Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00707902Phase 3Completed
Phase 3, randomised, double-blind trial of A. Vogel Sore Throat lozenges in pharyngitis and tonsillitis, sponsored by A.Vogel. Primary endpoint: Responder Rate after the first, second, and third days at 3 days. Started Feb 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00707902.